(Public, NASDAQ:BIOL)   Watch this stock  
Find more results for BIOL
-0.07 (-3.23%)
Mar 3 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.08 - 2.15
52 week 1.69 - 3.30
Open 2.14
Vol / Avg. 363,629.00/206,234.00
Mkt cap 125.51M
P/E     -
Div/yield     -
EPS -0.45
Shares 43.95M
Beta 2.41
Inst. own 60%
Mar 4, 2015
Q3 2014 BIOLASE Inc Earnings Call - 4:30PM EST - Add to calendar
Mar 4, 2015
Q3 2014 BIOLASE Inc Earnings Release Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -27.49% -20.35%
Operating margin -25.92% -19.49%
EBITD margin - -17.98%
Return on average assets -49.80% -36.44%
Return on average equity -200.23% -113.26%
Employees 220 -
CDP Score - -


IRVINE, CA 92618
United States - Map
+1-949-3611200 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


BIOLASE, Inc., formerly BIOLASE Technology, Inc., is a medical technology company that develops, manufactures and markets lasers, and markets and distributes dental imaging equipment and other related products designed for applications and procedures in dentistry and medicine. The Company's dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications in a minimally invasive manner. The Company also manufactures and sells disposable products and accessories for its laser systems. The Company's Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed. The Company also markets flexible fibers and hands pieces. For the Company's ezlase system, it sells tooth whitening gel kits.

Officers and directors

Paul N. Clark MBA Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Alexander K. J. Arrow M.D. Chief Medical Officer
Age: 45
Bio & Compensation  - Reuters
Jeffrey M. Nugent President, Chief Executive Officer, Director
Age: 67
Bio & Compensation  - Reuters
George W. Bickerstaff III Director
Age: 58
Bio & Compensation  - Reuters
Tamar D. Howson Director
Age: 66
Bio & Compensation  - Reuters
Terence A. Kelly Ph.D. Director
Age: 53
Bio & Compensation  - Reuters
Jonathan T. Lord M.D. Director
Age: 59
Bio & Compensation  - Reuters
Frederic H. Moll M.D. Director
Age: 60
Bio & Compensation  - Reuters